AcaHealth Pharma & Biotech Co.,LTD

長安醫藥生技 Innovative R&D

Our Timeline

2009
Start up AcaHealth Pharma & Biotech Company.
     
2011
Set up pilot plant for purification of AH-101-CVD from a anti-aging Chinese herb as chemical drug development.
     
2012
Pilot plant finished, started the process with SOP with GMP ccompliance.
     
2013
Development the crystallization technology for AH-101-CVD in Kg level (99.67% pure) in 2013.
     
2014
Commissioned to CRO for the genotoxicity of AH-101-CVD up to 5g/Kg in mice without any toxicity.
     
2015
Commissioned to CRO for the 3 months repeated dose toxicology up to 2.5g/Kg in rat without any toxicity.
     
2016
AcaHealth granted a SBIR to support the safety pharmacology including beagle dog.
     
2016
Finished safety pharmacology including beagle dog without any harmful effect in 2016.
     
2017
Purchased 3 factories for AcaHealth company in June 2017.
     
2018
Established Research Center and New herbal Industrial & Cultural Hall.
     
2018
Commissioned to CRO for the 3 months repeated dose toxicology up to 640mg/Kg in beagle dog without any toxicity.
     
2018
A US material patent (AH-101-CVD derivatives) for unmet medical need was granted on 06/26/2018.
     
2018
Submitted IND to US FDA in Sep.
     
2020
Granted IND from US FDA in Jan 23.
     
2020
Submitted to TFDA in Apr.

 

←BACK

Copyright © 2020 長安醫藥生技 AcaHealth Pharma & Biotech Company

WebMake SiteBuild | HiYP B2B Service | TaiwanDNS